Somatic studies have revealed that some TP53 missense variants generate immunogenic neoantigens presented by MHC-I, but the potential role of neoantigenicity in inherited cancer syndromes such as LFS has not been investigated. Here, TP53 is linked to Li-Fraumeni syndrome.